349 related articles for article (PubMed ID: 12220139)
1. Status of NAT screening for HCV, HIV and HBV--experiences of the German Red Cross Blood Donation Services.
Seifried E; Findhammer S; Roth WK
Dev Biol (Basel); 2002; 108():23-7. PubMed ID: 12220139
[No Abstract] [Full Text] [Related]
2. Status of NAT screening for HCV, HIV and HBV: experience in Japan.
Tomono T; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Murozuka T; Emura H; Doi Y; Mine H; Yokoyama S; Ohnuma H; Tanaka T; Yoshikawa A; Nishioka K;
Dev Biol (Basel); 2002; 108():29-39. PubMed ID: 12220140
[TBL] [Abstract][Full Text] [Related]
3. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
4. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
Nübling CM; Unkelbach U; Chudy M; Seitz R
Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
[TBL] [Abstract][Full Text] [Related]
5. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
6. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
7. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.
Dettori S; Candido A; Kondili LA; Chionne P; Taffon S; Genovese D; Iudicone P; Miceli M; Rapicetta M
J Infect; 2009 Aug; 59(2):128-33. PubMed ID: 19586663
[TBL] [Abstract][Full Text] [Related]
8. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.
Mine H; Emura H; Miyamoto M; Tomono T; Minegishi K; Murokawa H; Yamanaka R; Yoshikawa A; Nishioka K;
J Virol Methods; 2003 Sep; 112(1-2):145-51. PubMed ID: 12951223
[TBL] [Abstract][Full Text] [Related]
9. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
[TBL] [Abstract][Full Text] [Related]
10. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.
Yoshikawa A; Gotanda Y; Itabashi M; Minegishi K; Kanemitsu K; Nishioka K;
Vox Sang; 2005 Feb; 88(2):77-86. PubMed ID: 15720604
[TBL] [Abstract][Full Text] [Related]
11. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.
Hourfar MK; Schmidt M; Seifried E; Roth WK
Vox Sang; 2005 Aug; 89(2):71-6. PubMed ID: 16101686
[TBL] [Abstract][Full Text] [Related]
14. Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes.
Schmidt M; Pichl L; Jork C; Hourfar MK; Schottstedt V; Wagner FF; Seifried E; Müller TH; Bux J; Saldanha J
Vox Sang; 2010 Jan; 98(1):37-46. PubMed ID: 19682348
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.
Margaritis AR; Brown SM; Seed CR; Kiely P; D'Agostino B; Keller AJ
Transfusion; 2007 Oct; 47(10):1783-93. PubMed ID: 17880602
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; van Drimmelen H; David B; Lelie N; De Micco P
Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
[TBL] [Abstract][Full Text] [Related]
17. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
[TBL] [Abstract][Full Text] [Related]
18. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
[TBL] [Abstract][Full Text] [Related]
19. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
20. The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden.
Davidson T; Ekermo B; Gaines H; Lesko B; Åkerlind B
Transfusion; 2011 Feb; 51(2):421-9. PubMed ID: 20849409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
